CYC Insider Trading

Insider Ownership Percentage: 54.89%
Insider Buying (Last 12 Months): A$20,400.00
Insider Selling (Last 12 Months): A$0.00

Cyclopharm Insider Trading History Chart

This chart shows the insider buying and selling history at Cyclopharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cyclopharm Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CYC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Cyclopharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2023James McBrayerInsiderExercise200,000A$1.31A$262,000.00
10/31/2023David HeaneyInsiderBuy10,000A$2.04A$20,400.00
12/2/2022Kevin BarrowInsiderBuy10,000A$1.38A$13,800.00
11/29/2022Dianne AngusInsiderBuy1,254A$1.30A$1,630.20
6/14/2022David HeaneyInsiderBuy10,000A$1.15A$11,450.00
5/19/2022David HeaneyInsiderBuy5,500A$1.36A$7,480.00
3/9/2022David HeaneyInsiderBuy10,000A$1.49A$14,860.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Cyclopharm (ASX:CYC)

13.74% of Cyclopharm stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Read More on Cyclopharm

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

10,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

0.58%

Beta

0.79

Who are the company insiders with the largest holdings of Cyclopharm?

Cyclopharm's top insider shareholders include:
  1. David Heaney (Insider)
  2. Dianne Angus (Insider)
  3. James McBrayer (Insider)
  4. Kevin Barrow (Insider)
Learn More about top insider investors at Cyclopharm.